Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
aboutPureVision, ActivitiesIn, ActivityIn, acuity, addressing, ain, air, Alcon, amoun, andDecember, andproprietary, andSensitive, andStorz, andZylet, antibiotic, AO, areBausch, arly, Aronex, aspheric, ASTM, attestation, auditor, automation, beta, billion, Biovail, blade, bothAlrexandLotemax, bothZyoptix, Brazil, bsp, Carolina, carotene, carrier, center, cert, challenged, chan, chapter, circumstance, cleanup, Clearwater, competitor, consecutive, consignment, constituted, cont, contrast, convince, copy, corticosteroid, coverage, dedicated, deduction, degree, demographic, detect, detection, DevelopmentResearch, Dial, differentiated, disciplined, dispensed, Document, dominated, dosage, doubled, drop, easy, efficiency, efficiently, EMEA, encouraging, enniumline, EnvironmentOur, EPS, especiallyOcuvite, Evon, exceed, expressed, extremely, fall, fatty, feedback, fering, Fitch, fitting, foregoing, forLotemax, forMedalist, forRetisertimplant, forZyletophthalmic, framework, Frameworkissued, freeze, freezing, fromZyoptix, fromZyoptixsystem, frozen, gel, ging, Greenville, heBausch, HedgesAt, HedgesDuring, Henry, hourly, ight, inadequate, incidence, includingOcuvitePreserVision, IncomeThe, India, individually, ineligible, infrastructure, inInternal, inOther, installation, installed, IntangiblesThe, intensely, interacting, introducedReNu, introduceLotemax, inZyoptix, ip, isposal, ith, largest, launchedReNu, launchedZylet, launchMedalist, launchReNu, launchReNuMultiPlusin, law, Lean, li, LLP, load, lutein, Malaysia, ManufacturingIn, MarketsWe, max, McKinsey, microsurgical, Missouri, module, mpany, MultiPlussolution, myopia, nbs, nes, newly, noncontributory, nutritional, ObligationThe, occupational, offshore, ofLotemax, ofMedalist, ofSofPort, ofZylet, ond, opportunity, optical, organizational, oth, otherOcuvite, ourBoston, OurHansatome, ourMedalist, ourMill, ourRetisert, ourSofPort, outpatient, outr, pany, partnersh, passed, Paymentrequiring, penetration, perfecting, Pharmacia, pipeline, PlansThe, podium, population, possession, posterior, prescripti, preserv, PreserVisionbrand, prevailed, prohibited, prolonged, proportionate, protein, publicly, purcha, question, reallocated, reallocation, RefractiveSurgery, Regionand, RegistrantSet, RegulationOur, relaunch, remainin, render, rendered, repatriate, repatriating, repatriation, resolved, rest, retiree, retroactively, RGP, robust, rollout, salaried, Scotland, se, seeNew, SegmentsFor, Singapore, smaller, social, solid, South, spring, stable, StatusThe, storage, stream, stricter, surgeon, suspension, SVS, Tampa, tendered, theLote, theMedalist, thePureVisionfamily, thePureVisionToric, thirty, tobramycin, Treadway, Tung, ubsidiary, unauthorized, uncertain, unearned, unique, user, visibility, visual, vitrectomy, warehousing, water, Waterfo, weekly, West, withMoistureLoc, withMoistureLocinto, written, XP
Removed:
alleged, alleging, andBoston, Aron, artificially, Australia, commenced, comparison, Delaware, Duesseldorf, environment, EVA, false, fee, FW, Georgia, inflated, Kellogg, leased, listing, Lotemax, Marie, master, Melbourne, misleading, motion, Northern, Ocuvite, Orbscan, power, purevision, seek, Smith, trial, vigorously
Filing tables
Filing exhibits
- 10-K Annual report
- 4 Sixth Supplemental Indenture
- 10 Annual Incentive Compensation Plan
- 10 Employment Terms PGH
- 12 Ratio of Earnings to Fixed Charges
- 21 Subsidiaries
- 23 Consent of Independent Registered Public Accounting Firm
- 24 Power of Attorney
- 31 Section 302 CEO Certification
- 31 Section 302 CFO Certification
- 32 Section 906 CEO Certification
- 32 Section 906 CFO Certification
- 99 Information Concerning Forward-looking Statements
Related press release
Bausch & Lomb similar filings
Filing view
External links
Bausch & Lomb Incorporated
Exhibit 12
Statement Regarding Computation of Ratio of Earnings to Fixed Charges
(Dollar Amounts In Millions)
December 25, 2004 | December 27, 2003 | |
Income before Income Taxes and Minority Interest | $246.8 | $197.0 |
Fixed Charges | 50.1 | 54.7 |
Current Period Amortization of Capitalized Interest | 0.5 | 0.2 |
Capitalized Interest | (1.1) | (1.1) |
Total Earnings as Adjusted | $296.3 | $250.8 |
Fixed Charges | ||
Interest (Including Interest Expense and Capitalized Interest) | $ 49.5 | $ 54.2 |
Portion of Rents Representative of the Interest Factor | 0.6 | 0.5 |
Total Fixed Charges | $ 50.1 | $ 54.9 |
Ratio of Earnings to Fixed Charges | 5.9 | 4.6 |